1. Home
  2. BLUE
  3. BLUE News

Latest bluebird bio Inc. (BLUE) News on November 22, 2024

bluebird bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
BLUE

Simply Wall St.

6 days ago

bluebird bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options
BLUE

Benzinga

7 days ago

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options

bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
BLUE

GuruFocus.com

7 days ago

bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

Bluebird Bio (BLUE) Reports Q3 Loss, Lags Revenue Estimates
BLUE

Zacks

8 days ago

Bluebird Bio (BLUE) Reports Q3 Loss, Lags Revenue Estimates

BLUE

Associated Press Finance

8 days ago

Bluebird: Q3 Earnings Snapshot

bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
BLUE

Business Wire

8 days ago

bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance

bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call
BLUE

Business Wire

16 days ago

bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call

bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
BLUE

Business Wire

17 days ago

bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies
BLUE

Insider Monkey

22 days ago

bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies

Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy
BLUE

Benzinga

a month ago

Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy

Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials
BLUE

Pharmaceutical Technology

a month ago

Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BLUE

Business Wire

2 months ago

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BLUE

Associated Press Finance

2 months ago

Bluebird: Q2 Earnings Snapshot

bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing
BLUE

Business Wire

2 months ago

bluebird bio Announces Completion of its Q2 2024 Form 10-Q Filing

Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year
BLUE

Benzinga

2 months ago

Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is Workforce By 25%, Seeks To Breakeven Next Year

BLUE

MT Newswires

2 months ago

Bluebird Bio to Reduce Workforce by 25% as Part of Restructuring

bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025
BLUE

Business Wire

2 months ago

bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025

BLUE

Associated Press Finance

2 months ago

Bluebird: Q1 Earnings Snapshot

bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q
BLUE

Business Wire

2 months ago

bluebird bio Announces Completion of its Restatement and filing of its 2023 Form 10-K and Q1 2024 Form 10-Q

FDA will not meet ahead of bluebird bio’s sickle cell disease gene therapy PDUFA date
BLUE

Pharmaceutical Technology

3 months ago

FDA will not meet ahead of bluebird bio’s sickle cell disease gene therapy PDUFA date

bluebird bio Announces September Investor Events
BLUE

Business Wire

3 months ago

bluebird bio Announces September Investor Events

BLUE

MT Newswires

3 months ago

bluebird bio Gets Nasdaq Noncompliance Notice

bluebird bio Announces Receipt of Expected Notices from Nasdaq
BLUE

Business Wire

3 months ago

bluebird bio Announces Receipt of Expected Notices from Nasdaq

bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
BLUE

Business Wire

3 months ago

bluebird bio Reports Second Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance

bluebird bio Announces Second Quarter 2024 Results Call Date
BLUE

Business Wire

3 months ago

bluebird bio Announces Second Quarter 2024 Results Call Date

bluebird bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BLUE

Business Wire

4 months ago

bluebird bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

With 57% ownership of the shares, bluebird bio, Inc. (NASDAQ:BLUE) is heavily dominated by institutional owners
BLUE

Simply Wall St.

4 months ago

With 57% ownership of the shares, bluebird bio, Inc. (NASDAQ:BLUE) is heavily dominated by institutional owners

HHS gives thumbs down to bluebird’s fertility support programme
BLUE

Pharmaceutical Technology

4 months ago

HHS gives thumbs down to bluebird’s fertility support programme

bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)
BLUE

Business Wire

5 months ago

bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)

2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner
BLUE

PR Newswire

6 months ago

2Flo Ventures Announces Addition of Renowned Life Sciences Executive Charlotte Jones-Burton, MD, MS as a Partner

bluebird bio Appoints O. James Sterling as Chief Financial Officer
BLUE

Business Wire

6 months ago

bluebird bio Appoints O. James Sterling as Chief Financial Officer

BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
BLUE

TipRanks

6 months ago

BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?

Is Bluebird Bio Stock a Buy?
BLUE

Motley Fool

6 months ago

Is Bluebird Bio Stock a Buy?

BLUE

GuruFocus.com

6 months ago

bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...

bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
BLUE

Zacks

6 months ago

bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well

bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance
BLUE

Business Wire

6 months ago

bluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance

bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events
BLUE

Business Wire

7 months ago

bluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor Events

bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy
BLUE

Business Wire

7 months ago

bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy

BLUE

MT Newswires

7 months ago

bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report

bluebird bio Announces Receipt of Expected Notice from Nasdaq
BLUE

Business Wire

7 months ago

bluebird bio Announces Receipt of Expected Notice from Nasdaq

Is Bluebird Bio Stock a Buy?
BLUE

Motley Fool

7 months ago

Is Bluebird Bio Stock a Buy?

Better Buy: Bluebird Bio Vs. Novavax
BLUE

Motley Fool

7 months ago

Better Buy: Bluebird Bio Vs. Novavax

Is This Beaten-Down Stock a Good Acquisition Target?
BLUE

Motley Fool

7 months ago

Is This Beaten-Down Stock a Good Acquisition Target?

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BLUE

Business Wire

7 months ago

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript
BLUE

Insider Monkey

8 months ago

bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript

Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
BLUE

Motley Fool

8 months ago

Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst

bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
BLUE

Business Wire

8 months ago

bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance

bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call
BLUE

Business Wire

8 months ago

bluebird bio to Host Fourth Quarter and 2023 Annual Results Conference Call

Why Bluebird Bio Stock Flew Higher Than the Market Today
BLUE

Motley Fool

8 months ago

Why Bluebird Bio Stock Flew Higher Than the Market Today

bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital
BLUE

Business Wire

8 months ago

bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital

Is Bluebird Bio Stock a Buy Now?
BLUE

Motley Fool

8 months ago

Is Bluebird Bio Stock a Buy Now?

bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
BLUE

Business Wire

8 months ago

bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy

Why Bluebird Bio Stock Dived Into the Red on Tuesday
BLUE

Motley Fool

9 months ago

Why Bluebird Bio Stock Dived Into the Red on Tuesday

bluebird bio, Inc.'s (NASDAQ:BLUE) top owners are retail investors with 51% stake, while 49% is held by institutions
BLUE

Simply Wall St.

10 months ago

bluebird bio, Inc.'s (NASDAQ:BLUE) top owners are retail investors with 51% stake, while 49% is held by institutions

RADIANT LOGISTICS TO HOST INVESTOR CALL TO DISCUSS FINANCIAL RESULTS FOR SECOND FISCAL QUARTER ENDED DECEMBER 31, 2023
BLUE

PR Newswire

10 months ago

RADIANT LOGISTICS TO HOST INVESTOR CALL TO DISCUSS FINANCIAL RESULTS FOR SECOND FISCAL QUARTER ENDED DECEMBER 31, 2023

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?
BLUE

Zacks

10 months ago

Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?

Ring Energy Announces Production Results and Continued Debt Reduction for Fourth Quarter 2023 and Partial Guidance for the First Quarter 2024
BLUE

GlobeNewswire

10 months ago

Ring Energy Announces Production Results and Continued Debt Reduction for Fourth Quarter 2023 and Partial Guidance for the First Quarter 2024

If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
BLUE

Motley Fool

10 months ago

If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today

Viemed Healthcare, Inc.'s (NASDAQ:VMD) institutional shareholders had a great week as one-year returns increased after a 12% gain last week
BLUE

Simply Wall St.

10 months ago

Viemed Healthcare, Inc.'s (NASDAQ:VMD) institutional shareholders had a great week as one-year returns increased after a 12% gain last week

Heritage Commerce Corp Earns $13.3 Million for the Fourth Quarter of 2023, and $64.4 Million for the Full Year 2023
BLUE

GlobeNewswire

10 months ago

Heritage Commerce Corp Earns $13.3 Million for the Fourth Quarter of 2023, and $64.4 Million for the Full Year 2023

INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
BLUE

PR Newswire

10 months ago

INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader

BLUE

GlobeNewswire

10 months ago

Diamond Equity Research to Host Spotlight Emerging Growth Invitational Virtual Investor Conference on January 23, 2024

Banner (BANR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
BLUE

Zacks

10 months ago

Banner (BANR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

NGL Energy Partners LP Announces $700 Million Senior Secured Term Loan Facility and Provides Financial Update
BLUE

Business Wire

10 months ago

NGL Energy Partners LP Announces $700 Million Senior Secured Term Loan Facility and Provides Financial Update

2 Red Flags for Bluebird Bio Stock
BLUE

Motley Fool

10 months ago

2 Red Flags for Bluebird Bio Stock

Univest Financial Corporation to Hold Fourth Quarter 2023 Earnings Call
BLUE

GlobeNewswire

10 months ago

Univest Financial Corporation to Hold Fourth Quarter 2023 Earnings Call

bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
BLUE

Business Wire

10 months ago

bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook

Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference
BLUE

GlobeNewswire

10 months ago

Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference

Leftovers: Dunkin’ muscles into protein powder | Danone whips up International Delight cold foam creamer
BLUE

Food Dive

a year ago

Leftovers: Dunkin’ muscles into protein powder | Danone whips up International Delight cold foam creamer

Bluebird’s Plans to Win in Sickle Cell Come Into Focus
BLUE

The Wall Street Journal

a year ago

Bluebird’s Plans to Win in Sickle Cell Come Into Focus

When Will Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Turn A Profit?
BLUE

Simply Wall St.

a year ago

When Will Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Turn A Profit?

Absci to Participate in the 26th Annual Needham Growth Conference
BLUE

GlobeNewswire

a year ago

Absci to Participate in the 26th Annual Needham Growth Conference

Better Risky Investment: Bluebird Bio vs. Shiba Inu
BLUE

Motley Fool

a year ago

Better Risky Investment: Bluebird Bio vs. Shiba Inu

bluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BLUE

Business Wire

a year ago

bluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
BLUE

GlobeNewswire

a year ago

Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration

Opthea to Receive US$35M Commitment and Additional US$50M Funding
BLUE

GlobeNewswire

a year ago

Opthea to Receive US$35M Commitment and Additional US$50M Funding

Should You Invest in Bluebird Bio Right Now?
BLUE

Motley Fool

a year ago

Should You Invest in Bluebird Bio Right Now?

Mission Produce, Inc. (NASDAQ:AVO) Q4 2023 Earnings Call Transcript
BLUE

Insider Monkey

a year ago

Mission Produce, Inc. (NASDAQ:AVO) Q4 2023 Earnings Call Transcript

Should You Investigate The Shyft Group, Inc. (NASDAQ:SHYF) At US$12.76?
BLUE

Simply Wall St.

a year ago

Should You Investigate The Shyft Group, Inc. (NASDAQ:SHYF) At US$12.76?

Gold Royalty Completes Acquisition of Québec Royalty Portfolio
BLUE

CNW Group

a year ago

Gold Royalty Completes Acquisition of Québec Royalty Portfolio

Mission Produce (NASDAQ:AVO) Misses Q4 Sales Targets
BLUE

StockStory

a year ago

Mission Produce (NASDAQ:AVO) Misses Q4 Sales Targets

BLUE

Business Wire

a year ago

Mitek Appoints David Lyle as Chief Financial Officer

Opthea Receives A$8.8 million R&D Tax Incentive
BLUE

GlobeNewswire

a year ago

Opthea Receives A$8.8 million R&D Tax Incentive

BLUE

Business Wire

a year ago

Mitek Announces Receipt of Notice from Nasdaq

Consumer Acceptance of Biometrics Opens Path to Confront Threat of AI Digital Fraud
BLUE

Business Wire

a year ago

Consumer Acceptance of Biometrics Opens Path to Confront Threat of AI Digital Fraud

7 Stock Winners That Are Up 1,000% or More in 2023
BLUE

InvestorPlace

a year ago

7 Stock Winners That Are Up 1,000% or More in 2023

Community Health Systems, Inc. Announces Pricing of Upsized Offering of Senior Secured Notes Due 2032
BLUE

Business Wire

a year ago

Community Health Systems, Inc. Announces Pricing of Upsized Offering of Senior Secured Notes Due 2032

Top 50 Places To Visit Before You Die
BLUE

Insider Monkey

a year ago

Top 50 Places To Visit Before You Die

Here's Why Momentum in Orange County Bancorp, Inc. (OBT) Should Keep going
BLUE

Zacks

a year ago

Here's Why Momentum in Orange County Bancorp, Inc. (OBT) Should Keep going

Innovid to Present at Upcoming Investor Conferences
BLUE

PR Newswire

a year ago

Innovid to Present at Upcoming Investor Conferences

While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most
BLUE

Simply Wall St.

a year ago

While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most

BLUE

GuruFocus.com

a year ago

Star Group LP (SGU) Faces Decline in Q4 Revenue Amid Market Volatility

Star Group, L.P. Reports Fiscal 2023 Fourth Quarter Results
BLUE

GlobeNewswire

a year ago

Star Group, L.P. Reports Fiscal 2023 Fourth Quarter Results

Sidoti Events, LLC's Virtual December Small-Cap Conference
BLUE

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual December Small-Cap Conference

OFG Bancorp (OFG) Hit a 52 Week High, Can the Run Continue?
BLUE

Zacks

a year ago

OFG Bancorp (OFG) Hit a 52 Week High, Can the Run Continue?

National Vision Holdings, Inc. (NASDAQ:EYE) Shares Could Be 33% Above Their Intrinsic Value Estimate
BLUE

Simply Wall St.

a year ago

National Vision Holdings, Inc. (NASDAQ:EYE) Shares Could Be 33% Above Their Intrinsic Value Estimate

Opthea to Present at the FLORetina 2023 Congress
BLUE

GlobeNewswire

a year ago

Opthea to Present at the FLORetina 2023 Congress

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
BLUE

GlobeNewswire

a year ago

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer

Zacks.com featured highlights Freshpet, OptimizeRx and Pinterest
BLUE

Zacks

a year ago

Zacks.com featured highlights Freshpet, OptimizeRx and Pinterest

Should You Be Excited About Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) 20% Return On Equity?
BLUE

Simply Wall St.

a year ago

Should You Be Excited About Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) 20% Return On Equity?

Share on Social Networks: